Health Care: Drugs

Exelixis Inc (EXEL: NASDAQ)

$20.91 n/a | n/a%
03/24/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 191.45M 37.17M 25.11M 31.34M
Cost of Sales 6.55M 3.90M 2.04M 1.12M
Gross Operating Profit 184.90M 33.28M 23.07M 30.22M
Selling, General, and Administrative Expenses 116.14M 57.30M 50.83M 50.96M
Research & Development 95.97M 96.35M 189.10M 178.76M
Operating Income before D & A (EBITDA) -27.21M -120.38M -216.86M -199.50M
Depreciation & Amortization 9.43M 18.45M 24.68M 29.44M
Interest Income 4.86M 412.00K 4.34M 1.22M
Other Income - Net -13.90M 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -46.60M -139.46M -244.80M -228.95M
Interest Expense 33.06M 40.68M 41.36M 45.35M
Pre-Tax Income -79.66M -180.14M -286.16M -274.29M
Income Taxes 0.00 55.00K -182.00K -96.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -70.22M -161.74M -261.30M -244.76M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -70.22M -161.74M -261.30M -244.76M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -70.22M -161.74M -261.30M -244.76M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-69.31M -160.70M -253.70M -243.53M
Preferred Dividends
Net Income Available To Common -70.22M -161.74M -261.30M -244.76M
Basic EPS from Continuing Ops. -0.28 -0.77 -1.34 -1.33
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.28 -0.77 -1.34 -1.33
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.28 -0.77 -1.34 -1.33
Basic Normalized Net Income/Share -0.28 -0.77 -1.30 -1.32
EPS fr Continuing Ops. -0.28 -0.77 -1.34 -1.33
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.28 -0.77 -1.34 -1.33
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.28 -0.77 -1.34 -1.33
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.28 -0.77 -1.30 -1.32
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with EXEL

Latest EXEL Headlines from TheStreet

More Financial News for EXEL

Press Releases for EXEL

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter